Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0000950170-24-003466

Chief Executive Officer acquired 43,750 shares (grant or award)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Townsend Richard Nolan · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-05 Grant or award : show line 1 in the form 10b5-1 +43,750 170,695 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-05 Grant or award : show line 2 in the form 10b5-1 Stock Option (Right to Buy) +262,500 262,500 D
Loading xslF345X05/ownership.xml…